Our findings that ADAR editing patterns differ in PD from what may be indicative of healthy aging processes suggests that not only changes in editing enzymes are dynamic between ages and disease, but also that the way that genes are being edited—such as locations and/or level of specific editing events within transcripts—may have downstream significance. This evidence concerns the gene ADAR and Parkinson disease.